To investigate the clinical significance of fibronectin in HCC, we classified these 52 patients into 2 groups: fibronectin high (IHC score≥3) and low (IHC score≤2), and analyzed the association between fibronectin expression status and certain clinicopathological characteristics. The gene discussed is FN1; the disease is hepatocellular carcinoma.